Metabolic stress-induced activation of FoxO1 triggers diabetic cardiomyopathy in mice.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Clinical Investigation

• Publication date

  2012-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI60329PMID 22326951PMCID PMC3287230
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

  2011cited by this paper
• Heart disease and stroke statistics--2011 update: a report from the American Heart Association.

  2011cited by this paper
• Targeting Forkhead Box O1 from the Concept to Metabolic Diseases: Lessons from Mouse Models

  2011cited by this paper
• Chronic Inhibition of Pyruvate Dehydrogenase in Heart Triggers an Adaptive Metabolic Response*

  2011cited by this paper
• Lipotoxicity in the heart.

  2010cited by this paper
• The FoxO family in cardiac function and dysfunction.

  2010cited by this paper
• Diabetic cardiomyopathy: signaling defects and therapeutic approaches

  2010cited by this paper
• Diabetic Cardiomyopathy: Mechanisms and Therapeutic Targets.

  2010cited by this paper
• Diabetic cardiomyopathy, causes and effects

  2010cited by this paper
• Insulin Receptor Substrates Irs1 and Irs2 Coordinate Skeletal Muscle Growth and Metabolism via the Akt and AMPK Pathways

  2010cited by this paper
• Role of fatty acid uptake and fatty acid beta-oxidation in mediating insulin resistance in heart and skeletal muscle.

  2010cited by this paper
• Fatty Acid (FFA) Transport in Cardiomyocytes Revealed by Imaging Unbound FFA Is Mediated by an FFA Pump Modulated by the CD36 Protein*

  2010cited by this paper
• Insulin signaling meets mitochondria in metabolism.

  2010cited by this paper
• FoxO, Autophagy, and Cardiac Remodeling

  2010cited by this paper
• Modulation of myocardial metabolism: an emerging therapeutic principle

  2010cited by this paper
• Current views on type 2 diabetes.

  2010influential reference
• Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

  2010cited by this paper
• Degradation of IRS1 leads to impaired glucose uptake in adipose tissue of the type 2 diabetes mouse model TALLYHO/Jng.

  2009cited by this paper
• Increased Glucose Uptake and Oxidation in Mouse Hearts Prevent High Fatty Acid Oxidation but Cause Cardiac Dysfunction in Diet-Induced Obesity

  2009cited by this paper
• Avoidance of Transient Cardiomyopathy in Cardiomyocyte-Targeted Tamoxifen-Induced MerCreMer Gene Deletion Models

  2009cited by this paper
• Mechanisms for increased myocardial fatty acid utilization following short-term high-fat feeding.

  2009cited by this paper
• Insulin signaling regulating genes: effect on T2DM and cardiovascular risk

  2009cited by this paper
• FoxO Transcription Factors Promote Autophagy in Cardiomyocytes*

  2009cited by this paper
• Phosphatases at the heart of FoxO metabolic control.

  2008cited by this paper
• Overexpression of pyruvate dehydrogenase kinase 4 in heart perturbs metabolism and exacerbates calcineurin-induced cardiomyopathy.

  2008cited by this paper
• Diabetic cardiomyopathy: how much does it depend on AGE?

  2008cited by this paper
• Insulin-resistant cardiomyopathy clinical evidence, mechanisms, and treatment options.

  2008cited by this paper
• FoxO transcription factors activate Akt and attenuate insulin signaling in heart by inhibiting protein phosphatases

  2007influential reference
• Sex differences in energy metabolism and performance of teleost cardiac tissue.

  2007cited by this paper
• Foxo Transcription Factors Blunt Cardiac Hypertrophy by Inhibiting Calcineurin Signaling

  2006cited by this paper
• Diabetic cardiomyopathy: the search for a unifying hypothesis.

  2006cited by this paper
• Remodeling of Early-Phase Repolarization: A Mechanism of Abnormal Impulse Conduction in Heart Failure

  2006cited by this paper
• The reciprocal stability of FOXO1 and IRS2 creates a regulatory circuit that controls insulin signaling.

  2006cited by this paper
• Role of changes in cardiac metabolism in development of diabetic cardiomyopathy.

  2006cited by this paper
• Cardiac dysfunction induced by high-fat diet is associated with altered myocardial insulin signalling in rats

  2005cited by this paper
• The FOXO3a Transcription Factor Regulates Cardiac Myocyte Size Downstream of AKT Signaling*

  2005cited by this paper
• Regulation of insulin signalling by hyperinsulinaemia: role of IRS-1/2 serine phosphorylation and the mTOR/p70 S6K pathway

  2005influential reference
• Diabetic cardiomyopathy: mechanisms, diagnosis and treatment.

  2004cited by this paper
• Insulin stimulates fatty acid transport by regulating expression of FAT/CD36 but not FABPpm.

  2004cited by this paper
• Enhanced sarcolemmal FAT/CD36 content and triacylglycerol storage in cardiac myocytes from obese zucker rats.

  2004cited by this paper
• Insulin signaling in heart muscle: Lessons from genetically engineered mouse models

  2004cited by this paper
• Insulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction

  2003cited by this paper
• Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction.

  2003cited by this paper
• Insulin Signaling in Health and Disease

  2003cited by this paper
• Aldose Reductase Induced by Hyperosmotic Stress Mediates Cardiomyocyte Apoptosis

  2003cited by this paper
• Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway.

  2002influential reference
• Insulin stimulates long-chain fatty acid utilization by rat cardiac myocytes through cellular redistribution of FAT/CD36.

  2002cited by this paper
• The Forkhead Transcription Factor FoxO Regulates Transcription of p27Kip1 and Bim in Response to IL-21

  2002cited by this paper
• Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress

  2002cited by this paper
• Accuracy of echocardiographic estimates of left ventricular mass in mice.

  2001influential reference
• Serine/threonine phosphorylation of IRS-1 triggers its degradation: possible regulation by tyrosine phosphorylation.

  2001cited by this paper
• AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1

  2000cited by this paper
• Investigation

  2000cited by this paper
• Metabolic disturbances in diabetic cardiomyopathy

  1998cited by this paper
• Abnormal renal and hepatic glucose metabolism in type 2 diabetes mellitus.

  1998cited by this paper
• The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans

  1997cited by this paper
• Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia

  1997cited by this paper
• Role of diabetes in congestive heart failure: the Framingham study.

  1974cited by this paper
• New type of cardiomyopathy associated with diabetic glomerulosclerosis.

  1972cited by this paper

• Angiotensin-(1-9) attenuates diabetic cardiomyopathy by improving insulin resistance.

  2026cites this paper
• Glycophagy: molecular mechanisms, regulatory signals, and disease associations

  2026cites this paper
• Role of Hydrogen Sulfide Regulation of Programmed Cell Death: Implications for Cardiovascular Diseases

  2025cites this paper
• Intensity, Duration, and Context Dependency of the Responses to Nutrient Surplus and Deprivation Signaling in the Heart: Insights Into the Complexities of Cardioprotection

  2025cites this paper
• What Is Cardiometabolic HFpEF and How Can We Study it Preclinically?

  2025cites this paper
• A Molecular Perspective on the Intricate Interplay Among Exosomes, Bioenergetic Metabolism, and the Pathogenesis of Diabetic Cardiomyopathy

  2025cites this paper
• FoxO1-zDHHC4-CD36 S-Acylation Axis Drives Metabolic Dysfunction in Diabetes

  2025cites this paper
• Insulin modulates MMP-2 and 9 activities through the control of oxidative stress in the heart of diabetic rats Running title: Insulin modulates MMPs via oxidative stress control.

  2025cites this paper
• Diabetic cardiomyopathy: Mechanistic insights on molecular pathways and emerging therapeutic approaches

  2025cites this paper
• Invited: Longitudinal assessment of diets with varying carbohydrate-to-fat ratios and fiber supplementation on immunometabolic markers, liver function, and gut microbiome.

  2025cites this paper
• Identification of anoikis-related genes in heart failure: bioinformatics and experimental validation

  2025cites this paper
• Upregulated FoxO1 promotes arrhythmogenesis in mice with heart failure and preserved ejection fraction

  2025cites this paper
• O-GlcNAcylation-mediated endothelial metabolic memory contributes to cardiac damage via small extracellular vesicles.

  2025cites this paper
• Why the Diabetic Heart Is Fatty.

  2025cites this paper
• Vanadyl sulfate restores memory impairment in streptozotocin-induced rat model of sporadic alzheimer’s disease by repressing FoxO1 gene expression

  2025cites this paper
• Lipotoxicity as a therapeutic target in the type 2 diabetic heart.

  2025cites this paper
• Mitochondria at the Heart of Sepsis: Mechanisms, Metabolism, and Sex Differences

  2025cites this paper
• Cardiomyocyte-Specific FoxO1 Knockout Mice as Tools to Assess Cardiac Hypertrophy and Key Experimental Considerations Using Cre-loxP.

  2025cites this paper
• Clinical management of diabetic cardiomyopathy with insights into pathophysiology and diagnosis.

  2025cites this paper
• VCAM-1/Ezrin axis antagonizes myocardial damage in ischemia-reperfusion injury.

  2025cites this paper
• Metabolic Modulation of Pyruvate Dehydrogenase and Glucose Oxidationin Diabetic Cardiomyopathy: Pathways, Perspectives, and Potentials.

  2025cites this paper
• Cardiac substrate metabolism in type 2 diabetes

  2025cites this paper
• GYY4137 protects against type 2 diabetes mellitus-associated myocardial autophagy by suppressing FOXO1 signal pathway

  2024cites this paper
• Understanding Diabetic Cardiomyopathy: Insulin Resistance and Beyond.

  2024cites this paper
• The Effects of Metformin on Weight Loss, Cardiovascular Health, and Longevity.

  2024cites this paper
• Forkhead box O1 transcription factor; a therapeutic target for diabetic cardiomyopathy

  2024influential citation
• Elevated systemic total bile acids escalate susceptibility to alcohol-associated liver disease

  2024cites this paper
• Inhibition of the FOXO1-ROCK1 axis mitigates cardiomyocyte injury under chronic hypoxia in Tetralogy of Fallot by maintaining mitochondrial quality control.

  2024cites this paper
• SGLT2 inhibitor downregulates ANGPTL4 to mitigate pathological aging of cardiomyocytes induced by type 2 diabetes

  2024cites this paper
• Cardiac-specific Suv39h1 knockout ameliorates high-fat diet induced diabetic cardiomyopathy via regulating Hmox1 transcription.

  2024cites this paper
• The Influence of Metabolic Risk Factors on the Inflammatory Response Triggered by Myocardial Infarction: Bridging Pathophysiology to Treatment

  2024cites this paper
• Autophagy and mitophagy as potential therapeutic targets in diabetic heart condition: Harnessing the power of nanotheranostics

  2024cites this paper
• Post‐translational modifications in diabetic cardiomyopathy

  2024cites this paper
• In-depth phosphoproteomic profiling of the insulin signaling response in heart tissue and cardiomyocytes unveils canonical and specialized regulation

  2024cites this paper
• Redefining Diabetic Cardiomyopathy: Perturbations in Substrate Metabolism at the Heart of Its Pathology

  2024cites this paper
• Diabetes cardiomyopathy: targeted regulation of mitochondrial dysfunction and therapeutic potential of plant secondary metabolites

  2024cites this paper
• Lysophosphatidylcholine trigger myocardial injury in diabetic cardiomyopathy via the TLR4/ZNF480/AP-1/NF-kB pathway

  2024cites this paper
• Inhibition of the RPS6KA1/FoxO1 signaling axis by hydroxycitric acid attenuates HFD-induced obesity through MCE suppression.

  2024cites this paper
• Mitochondrial glycerol 3-phosphate dehydrogenase deficiency exacerbates lipotoxic cardiomyopathy

  2024cites this paper
• Targeting autophagy in diabetic cardiomyopathy: From molecular mechanisms to pharmacotherapy.

  2024cites this paper
• FRBM Mini REVIEW: Chemogenetic approaches to probe redox dysregulation in heart failure.

  2024cites this paper
• Tumor-Derived RAB21+ABHD12+ sEVs Drive the Premetastatic Microenvironment in the Lung.

  2024cites this paper
• The Relationship Between Cardiac Energy Metabolism and Cardiac Function in Obesity and Type 2 Diabetes: Revisiting a 2003 Diabetes Classic by Aasum et al.

  2024cites this paper
• Sex-specific regulation of the cardiac transcriptome by the protein phosphatase 2A regulatory subunit B55α

  2024cites this paper
• C1q and Tumor Necrosis Factor Related Protein 9 Protects from Diabetic Cardiomyopathy by Alleviating Cardiac Insulin Resistance and Inflammation

  2023cites this paper
• The Targeted Role of SGLT2 Inhibitors in Patients with Diabetic Cardiomyopathy

  2023cites this paper
• SIRT6: A potential therapeutic target for diabetic cardiomyopathy

  2023cites this paper
• Myristate induces mitochondrial fragmentation and cardiomyocyte hypertrophy through mitochondrial E3 ubiquitin ligase MUL1

  2023influential citation
• Eryngium billardieri extract affects cardiac gene expression of master regulators of cardiomyaopathy in rats with high fatdiet-induced insulin resistance.

  2023cites this paper
• Application of 4D-Ultrasound Derived Regional Strain and Proteomics Analysis in Nkx2-5 Deficient Male Mice.

  2023cites this paper
• Implications on growth performance, glucose metabolism, PI3K/AKT pathway, intestinal flora induced by dietary taurine in a high-carbohydrate diet for grass carp (Ctenopharyngodon idella)

  2023cites this paper
• Identification of hub genes associated with oxidative stress in heart failure and their correlation with immune infiltration using bioinformatics analysis

  2023cites this paper
• Zuogui Jiangtang Shuxin formula Ameliorates diabetic cardiomyopathy mice via modulating gut-heart axis

  2023cites this paper
• Western Diet Causes Heart Failure With Reduced Ejection Fraction and Metabolic Shifts After Diastolic Dysfunction and Novel Cardiac Lipid Derangements

  2023cites this paper
• Identification of Ferroptosis-Related Genes in Heart Failure Induced by Transverse Aortic Constriction

  2023cites this paper
• Lipoxin A4 prevents high glucose-induced inflammatory response in cardiac fibroblast through FOXO1 inhibition.

  2023cites this paper
• Cryptocaryone induces apoptosis in human hepatocellular carcinoma cells by inhibiting aerobic glycolysis through Akt and c-Src signaling pathways

  2023cites this paper
• Emerging links between FOXOs and diabetic complications.

  2023cites this paper
• Inhibition of Pyruvate Dehydrogenase in the Heart as an Initiating Event in the Development of Diabetic Cardiomyopathy

  2023cites this paper
• Effects of hypoxia in cardiac metabolic remodeling and heart failure.

  2023cites this paper
• A comprehensive review of the novel therapeutic targets for the treatment of diabetic cardiomyopathy

  2023cites this paper
• Myocardin-related transcription factor A, regulated by serum response factor, contributes to diabetic cardiomyopathy in mice.

  2023cites this paper
• Combined metabolomic and transcriptomic profiling approaches reveal the cardiac response to high-fat diet

  2022cites this paper
• Mfn2-mediated mitochondrial fusion alleviates doxorubicin-induced cardiotoxicity with enhancing its anticancer activity through metabolic switch

  2022cites this paper
• Plin5, a New Target in Diabetic Cardiomyopathy

  2022cites this paper
• Guidelines on models of diabetic heart disease

  2022cites this paper
• 2-Arachidonoylglycerol Attenuates Myocardial Fibrosis in Diabetic Mice Via the TGF-β1/Smad Pathway

  2022cites this paper
• Metabolites and Genes behind Cardiac Metabolic Remodeling in Mice with Type 1 Diabetes Mellitus

  2022cites this paper
• Metabolomic and Transcriptomic Signatures of Chemogenetic Heart Failure.

  2022cites this paper
• Molecular mechanisms underlying the beneficial effects of exercise and dietary interventions in the prevention of cardiometabolic diseases

  2022cites this paper
• Diabetes mellitus and heart failure: an update on pathophysiology and therapy.

  2022cites this paper
• Inflamed adipose tissue: A culprit underlying obesity and heart failure with preserved ejection fraction

  2022cites this paper
• Enhancement of glycolysis-dependent DNA repair regulated by FOXO1 knockdown via PFKFB3 attenuates hyperglycemia-induced endothelial oxidative stress injury

  2022cites this paper
• Metabolic, structural and biochemical changes in diabetes and the development of heart failure

  2022cites this paper
• Pyruvate Dehydrogenase Complex and Glucose Oxidation as a Therapeutic Target in Diabetic Heart Disease

  2022cites this paper
• Programming With Varying Dietary Fat Content Alters Cardiac Insulin Receptor, Glut4 and FoxO1 Immunoreactivity in Neonatal Rats, Whereas High Fat Programming Alters Cebpa Gene Expression in Neonatal Female Rats

  2022cites this paper
• Intermittent Fasting Improves High-Fat Diet-Induced Obesity Cardiomyopathy via Alleviating Lipid Deposition and Apoptosis and Decreasing m6A Methylation in the Heart

  2022cites this paper
• Pharmacological mechanism and clinical study of Qiming granules in treating diabetic retinopathy based on network pharmacology and literature review.

  2022cites this paper
• Energy substrate metabolism and oxidative stress in metabolic cardiomyopathy

  2022cites this paper
• Research status and trends of the diabetic cardiomyopathy in the past 10 years (2012–2021): A bibliometric analysis

  2022influential citation
• Myostatin/AKT/FOXO Signaling Is Altered in Human Non-Ischemic Dilated Cardiomyopathy

  2022cites this paper
• Diabetes-induced chronic heart failure is due to defects in calcium transporting and regulatory contractile proteins: cellular and molecular evidence

  2022cites this paper
• The impact of diet upon mitochondrial physiology (Review)

  2022cites this paper
• Vitamin A Preserves Cardiac Energetic Gene Expression in a Murine Model of Diet-Induced Obesity.

  2022cites this paper
• Modulation of the cell membrane lipid milieu by peroxisomal β-oxidation induces Rho1 signaling to trigger inflammatory responses.

  2022cites this paper
• Type 2 Diabetes Complicated With Heart Failure: Research on Therapeutic Mechanism and Potential Drug Development Based on Insulin Signaling Pathway

  2022cites this paper
• Adiponectin and metabolic cardiovascular diseases: Therapeutic opportunities and challenges

  2022cites this paper
• Perspectives for Forkhead box transcription factors in diabetic cardiomyopathy: Their therapeutic potential and possible effects of salvianolic acids

  2022cites this paper
• Heart Failure and Diabetes Mellitus: Biomarkers in Risk Stratification and Prognostication

  2021cites this paper
• Effect of C reactive protein on the sodium-calcium exchanger 1 in cardiomyocytes

  2021cites this paper
• FOXO1 and ANGPT2 relative gene expression in non-ST-segment elevation myocardial infarction among patients with or without type 2 diabetes

  2021cites this paper
• Endogenous asymmetric dimethylarginine accumulation precipitates the cardiac and mitochondrial dysfunctions in type 1 diabetic rats.

  2021cites this paper
• Pyridostigmine Protects Against Diabetic Cardiomyopathy by Regulating Vagal Activity, Gut Microbiota, and Branched-Chain Amino Acid Catabolism in Diabetic Mice

  2021cites this paper
• Insulin Signaling In the Heart.

  2021cites this paper
• Resolvin-D1 attenuation of Angiotensin II-induced cardiac inflammation in mice is associated with prevention of cardiac remodeling and hypertension.

  2021cites this paper
• FoxO1 inhibition alleviates type 2 diabetes-related diastolic dysfunction by increasing myocardial pyruvate dehydrogenase activity.

  2021cites this paper
• Kir6.1 improves cardiac dysfunction in diabetic cardiomyopathy via the AKT‐FoxO1 signalling pathway

  2021cites this paper
• NAD+ Repletion Reverses Heart Failure With Preserved Ejection Fraction

  2021cites this paper
• Calcineurin in the heart: New horizons for an old friend.

  2021cites this paper
• Autophagy in the Diabetic Heart: A Potential Pharmacotherapeutic Target in Diabetic Cardiomyopathy.

  2021cites this paper